Sources Sought Electronic Prescribing of Controlled Substances
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of State, Bureau of Medical Services (MED), is conducting a Sources Sought / Request for Information (RFI) to identify solutions for Electronic Prescribing (eRx), specifically including the Electronic Prescribing of Controlled Substances (EPCS). This RFI aims to gather information on systems that can enhance patient safety, streamline provider workflows, ensure regulatory compliance, and integrate with the Department's existing electronic medical system. Responses are due by April 10, 2026.
Scope of Work
MED is seeking information on solutions offering comprehensive eRx and EPCS capabilities. Key areas of interest include:
- Electronic Prescribing (eRx) Functionality: Creating, transmitting, and managing prescriptions; medication history access; drug-allergy and drug-drug interaction alerts; formulary access; and refill management.
- Electronic Prescribing of Controlled Substances (EPCS): Compliance with federal and state regulations (including DEA requirements); two-factor authentication; secure audit trails; integrated Prescription Drug Monitoring Program (PDMP) queries and automated checks; and display of recent controlled substance fill history.
- Integration: Capability to integrate with the Department’s electronic medical system using standard protocols (HL7, FHIR, APIs); support for single sign-on (SSO); and real-time data exchange.
- Security and Compliance: Adherence to HIPAA and HITECH regulations; robust data encryption; and comprehensive audit logs.
- User Experience and Support: Intuitive interface; comprehensive training materials and support; mobile and remote prescribing capabilities; and task dashboards.
- Clinical Safety & Decision Support: Real-time interaction checking (drug-drug, drug-allergy, drug-disease); duplicate therapy detection; dose range checking; and risk alerts.
- Reporting: Prescribing activity dashboards; antimicrobial stewardship reporting; and quality metric reporting.
Contract & Timeline
- Type: Sources Sought / Request for Information (RFI)
- Set-Aside: None specified
- Response Due: April 10, 2026, by 21:00 UTC
- Published: March 27, 2026
Evaluation
This RFI is for information and planning purposes only and does not constitute a solicitation or a promise to issue one. Responses will be used to inform future acquisition strategies.
Response Instructions
Interested parties should submit a written response detailing their company overview, proposed solution capabilities, integration experience, implementation/training/support details, case studies, estimated timelines, and any innovative features. Responses must be in PDF format and submitted electronically to Alicia Hofhine (HofhineAK@state.gov) by the due date. Questions should also be directed to Alicia Hofhine.